Y Chemfort™ inline set

A complete range of products adapted to any handling protocol.

?

References and additional materials

The closed Y-line set is a secondary set that connects securely between a standard IV bag or semi-rigid container and any IV administration set (gravity or pump).

The closed Y assembly has two connections: a tip connection to an IV bag or semi-rigid container containing saline and a Chemfort™ syringe adapter (SA) component that connects to the CP bag adapter.

Each connection has an individual roller clamp color to indicate the fluid path. The white roller clamp is for the saline and the purple roller clamp is for the drug.

During handling, simply click for a safe and secure connection between two Chemfort™ components. The Chemfort™ closed Y-line assembly is PVC DEHP free.

Video: Online Set Y Chemfort™

REFERENCES & PRODUCT INFORMATION

Asept InMed - N° identification 383600590, RCS Toulouse B 383 600 590 - The products presented are medical devices - The manufacturer, the class and the certification of the DM are informed in the legal mentions of the brochure - Non contractual photos - Information intended for health professionals.

Our team

Our specialists - hospital representatives - are there to accompany you in the discovery and testing of our products.

Luc Tran Van

Luc Tran Van

Product Specialist

Sandrine Corriger

Sandrine Corriger

Sales representative - Ile de France (Key accounts)

Nicolas Cortesi

Nicolas Cortesi

Sales representative - Ile de France

Sylvain Pruvot

Sylvain Pruvot

Sales Representative - North

Stéphanie Gonon

Stéphanie Gonon

Sales representative - Paca

Vincent Combourieu

Vincent Combourieu

Sales representative - Rhône-Alpes

Bastien Perray

Bastien Perray

Sales Representative - West

Julien Izard

Julien Izard

Sales Representative - South West

Virginie Pegurri

Virginie Pegurri

Sales Representative - East

You are a health professional and you want more information? Contact them!

If you are a home health care provider, contact our home team

Follow our news